AzTrials
AzTrials

Nonspecific Chronic Low Back PainNCT07033377

Psychometric Validation of Persian CBQ-NSCLBP

An observational study of Nonspecific Chronic Low Back Pain, run by Kourosh Najafi.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to translate, culturally adapt, and psychometrically validate the Persian version of the Cognitive Behavioral Questionnaire in Nonspecific Chronic Low Back Pain (CBQ-NSCLBP). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Nonspecific Chronic Low Back Pain
What is being tested?
Self-administered paper-based questionnaires
How many people
120 participants
Where
No sites listed yet
Study dates
Jul 2025to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults aged 18-65 years diagnosed with nonspecific chronic low back pain by a physician, who are fluent in Persian and able to complete questionnaires independently. Participants will be recruited from physiotherapy clinics and outpatient rehabilitation centers.

Who may be able to join

  • Age between 18 - 65 years old.
  • Experiencing nonspecific low back pain for at least 6 months.
  • Have a physician-confirmed diagnosis.
  • Be able to read and understand Persian.
  • Be willing to participate and provide written informed consent.

Who cannot join

  • Specific causes of low back pain (e.g., spinal infection, tumor, fracture, inflammatory disease, radiculopathy, or other neurological disorders).
  • Severe psychiatric disorders or cognitive impairments interfering with questionnaire comprehension.
  • History of surgery for low back pain.
  • Abnormal bowel or bladder function.
  • Pregnant at the time of participation.
  • Not fluent in Persian.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Cross-Cultural Adaptation and Psychometric Validation of the Persian Version of the Cognitive Behavioral Questionnaire in Nonspecific Chronic Low Back Pain

This study aims to translate, culturally adapt, and psychometrically validate the Persian version of the Cognitive Behavioral Questionnaire in Nonspecific Chronic Low Back Pain (CBQ-NSCLBP). The process will follow standard cross-cultural adaptation guidelines, including forward-backward translation, expert review, and pilot testing. The psychometric properties, including internal consistency, test-retest reliability, and construct validity, will be evaluated in a sample of Persian-speaking adults with nonspecific chronic low back pain.

Read the detailed description

Chronic low back pain (CLBP) is a common and persistent musculoskeletal condition that affects a large portion of the population and can lead to long-term disability. It is typically defined as pain in the lower back that lasts for more than 12 weeks and often impacts daily function and quality of life.

In addition to physical symptoms, people with CLBP frequently experience cognitive and behavioral challenges, such as fear-avoidance beliefs, catastrophizing, and difficulty concentrating. These factors can contribute to ongoing disability and interfere with the rehabilitation process.

The Cognitive Behavioral Questionnaire for Nonspecific Chronic Low Back Pain (CBQ-NSCLBP) was developed to assess these cognitive-behavioral aspects in people with nonspecific CLBP. However, it has only been validated in one population and has not yet been adapted for Persian-speaking individuals.

This study aims to translate and culturally adapt the CBQ-NSCLBP into Persian and evaluate its psychometric properties in individuals with nonspecific chronic low back pain

Being tested
Self-administered paper-based questionnaires
Keywords
chronic low back pain, CBQ-NSCLBP, Persian version, cross-cultural adaptation, psychometric validation, CLBP, cognitive behavioral questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-administered paper-based questionnairesOther

    Participants will complete the Persian version of the CBQ-NSCLBP and other self-report measures as part of a psychometric validation study. No clinical or therapeutic intervention is involved.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CBQ-NSCLBP

    Evaluation of the internal consistency, test-retest reliability, and construct validity of the Persian version of the Cognitive Behavioral Questionnaire in Nonspecific Chronic Low Back Pain (CBQ-NSCLBP).

    Measured: Baseline and within 6 to 10 days after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2025
  2. Study startJul 2025 (estimated)
  3. Primary completionNov 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07033377
Sponsor's protocol ID
MEDI-CBQNSCLBP-Pe
Status last verified
Jun 2025
First submitted
13 Jun 2025
Last updated
24 Jun 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Nonspecific Chronic Low Back Pain, run by Kourosh Najafi.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kourosh Najafi (+905398709096, kourosh.najafi@std.medipol.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CBQ-NSCLBP (time frame: Baseline and within 6 to 10 days after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in